Regulatory tracker: Japanese regulators greenlight meds from Amgen, Eli Lilly, Takeda and Nxera
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Tuesday, September 24 at …